Immune cell study in NIPAL4 ichthyosis
Treatments studied
Part of Blood & lymphatic, Cancer, Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study looks at the immune system (lymphocytes) in people with a specific genetic form of ichthyosis called NIPAL4-related ARCI. It aims to understand the condition better, which may lead to improved treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have autosomal recessive congenital ichthyosis (ARCI) caused by a mutation in the NIPAL4 gene.
- You cannot have ichthyosis that has not been genetically tested or is due to a different gene.
- You cannot have active infections, inflammatory diseases, or blood disorders.
- You cannot be under legal guardianship or curatorship.
- You must agree to participate in the research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “skin and blood biomarkers,” meaning measurable signs in the body, in people with ichthyosis to better understand the condition. It may help researchers find ways to track disease activity and evaluate future treatments.
This study follows people with rare “autoinflammatory” conditions and sometimes their blood relatives to understand why symptoms happen and how they change over time. It may help by improving diagnosis and care for these conditions, using stored samples and genetic testing.
This study looks for genetic causes of immune problems, such as unusually frequent infections, abnormal allergies, or autoimmune or inflammation conditions. It may help by improving how doctors understand these disorders and by matching families with possible genetic diagnoses.
This trial tests a tool (a way of collecting health information) to help doctors make better diagnosis, prognosis, and treatment decisions for children with certain immune problems. It also includes healthy children (like relatives) as comparison groups, to see how well the tool works.
This study looks at immune cells in people with certain autoimmune diseases or immune deficiencies. The goal is to understand how these cells work, which may help improve future treatments.
This trial looks at a protein called Interleukin-4 in patients with Pityriasis Lichenoides Chronica (PLC), a skin condition with bumps or light-colored spots. The goal is to better understand the condition and find new ways to help.
Hear when a new Sezary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.